219 related articles for article (PubMed ID: 15990436)
1. [Limitations of sentinel lymph node biopsy in breast cancer].
Fehr MK
Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):127-31. PubMed ID: 15990436
[TBL] [Abstract][Full Text] [Related]
2. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
3. [Sentinel lymph node biopsy in breast cancer: state of the art].
Bauerfeind I; Himsl I; Kühn T; Untch M; Hepp H
Gynakol Geburtshilfliche Rundsch; 2004 Apr; 44(2):84-91. PubMed ID: 15073437
[TBL] [Abstract][Full Text] [Related]
4. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
5. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node mapping and biopsy for ductal carcinoma in situ and other controversial indications.
Fuhrman GM
Am Surg; 2004 May; 70(5):403-6. PubMed ID: 15156947
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node in breast cancer.
James TA; Edge SB
Curr Opin Obstet Gynecol; 2006 Feb; 18(1):53-8. PubMed ID: 16493261
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy as the new standard of care in the surgical treatment for breast cancer.
Ferrari A; Rovera F; Dionigi P; Limonta G; Marelli M; Besana Ciani I; Bianchi V; Vanoli C; Dionigi R
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1503-15. PubMed ID: 17069533
[TBL] [Abstract][Full Text] [Related]
11. Sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.
Tanaka Y; Maeda H; Ogawa Y; Nishioka A; Itoh S; Kubota K; Ue H; Nakatani K; Sasaguri S
Oncol Rep; 2006 Apr; 15(4):927-31. PubMed ID: 16525681
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
[TBL] [Abstract][Full Text] [Related]
13. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important.
Jones JL; Zabicki K; Christian RL; Gadd MA; Hughes KS; Lesnikoski BA; Rhei E; Specht MC; Dominguez FJ; Smith BL
Am J Surg; 2005 Oct; 190(4):517-20. PubMed ID: 16164912
[TBL] [Abstract][Full Text] [Related]
14. [Sentinel lymphonodectomy -- new surgical standard for the evaluation of the axilla:an overview. Part 1].
Rageth CJ; Scholl B; Sarasin E; Saurenmann E
Gynakol Geburtshilfliche Rundsch; 2005 Jan; 45(1):28-38. PubMed ID: 15644638
[TBL] [Abstract][Full Text] [Related]
15. Surmounting the challenges of sentinel lymph node biopsy for breast cancer in non-tertiary centres and community-based practices.
Tan MP
ANZ J Surg; 2006 May; 76(5):306-9. PubMed ID: 16768687
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy in the management of breast cancer.
Kumar R; Bozkurt MF; Zhuang H; Alavi A
Indian J Cancer; 2003; 40(2):60-6. PubMed ID: 14716120
[TBL] [Abstract][Full Text] [Related]
17. What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?
Mabry H; Giuliano AE; Silverstein MJ
Am J Surg; 2006 Oct; 192(4):455-7. PubMed ID: 16978948
[TBL] [Abstract][Full Text] [Related]
18. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
19. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
[TBL] [Abstract][Full Text] [Related]
20. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]